Back to Search
ARTHUR PAVLOVSKY, MD
MD
Student in an Organized Health Care Education/Training Program
NPI: 1790579266Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
A randomised Phase III trial of glufosfamide compared with best supportive care in metastatic pancreatic adenocarcinoma previously treated with gemcitabine.
PMID 19188061·Eur J Cancer·2009
3-trial
2-Alkylamino- and alkoxy-substituted 2-amino-1,3,4-oxadiazoles-O-Alkyl benzohydroxamate esters replacements retain the desired inhibition and selectivity against MEK (MAP ERK kinase).
PMID 18951019·Bioorg Med Chem Lett·2008
8-other
Thermodynamic and structure guided design of statin based inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
PMID 18540668·J Med Chem·2008
7-preclinical
Is assessment of surface CD38 expression worthwhile as a prognostic factor in chronic lymphocytic leukemia patients?
PMID 18534062·Hematology·2008
8-other
The structural basis for allosteric inhibition of a threonine-sensitive aspartokinase.
PMID 18334478·J Biol Chem·2008
8-other
Examination of the mechanism of human brain aspartoacylase through the binding of an intermediate analogue.
PMID 18293939·Biochemistry·2008
8-other
Substituted pyrazoles as hepatoselective HMG-CoA reductase inhibitors: discovery of (3R,5R)-7-[2-(4-fluoro-phenyl)-4-isopropyl-5-(4-methyl-benzylcarbamoyl)-2H-pyrazol-3-yl]-3,5-dihydroxyheptanoic acid (PF-3052334) as a candidate for the treatment of hypercholesterolemia.
PMID 18072721·J Med Chem·2008
7-preclinical
4-anilino-5-carboxamido-2-pyridone derivatives as noncompetitive inhibitors of mitogen-activated protein kinase kinase.
PMID 17880056·J Med Chem·2007
7-preclinical
Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects.
PMID 17623656·J Biol Chem·2007
7-preclinical
Design and synthesis of hepatoselective, pyrrole-based HMG-CoA reductase inhibitors.
PMID 17574412·Bioorg Med Chem Lett·2007
7-preclinical
Design and synthesis of novel, conformationally restricted HMG-CoA reductase inhibitors.
PMID 17574411·Bioorg Med Chem Lett·2007
7-preclinical
Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions.
PMID 17488659·Haematologica·2007
4-observational
The initial step in the archaeal aspartate biosynthetic pathway catalyzed by a monofunctional aspartokinase.
PMID 17012784·Acta Crystallogr Sect F Struct Biol Cryst Commun·2006
8-other
Discovery of (1R,5S)-N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]- 3-[2(S)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide (SCH 503034), a selective, potent, orally bioavailable hepatitis C virus NS3 protease inhibitor: a potential therapeutic agent for the treatment of hepatitis C infection.
PMID 17004721·J Med Chem·2006
7-preclinical
Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition.
PMID 15543157·Nat Struct Mol Biol·2004
8-other
[Bilateral internal jugular thrombosis associated with thrombophilia after ovarian induction for infertility].
PMID 12325489·Medicina (B Aires)·2002
5-case
The structure of substrate-free microbial ribonuclease binase and of its complexes with 3'GMP and sulfate ions.
PMID 11976484·Acta Crystallogr D Biol Crystallogr·2002
8-other
Three-dimensional microwave tomography: initial experimental imaging of animals.
PMID 11794772·IEEE Trans Biomed Eng·2002
7-preclinical
4-Hydroxy-5,6-dihydropyrones as inhibitors of HIV protease: the effect of heterocyclic substituents at C-6 on antiviral potency and pharmacokinetic parameters.
PMID 11428926·J Med Chem·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 101 THE CITY DR S
ORANGE, CA 92868 - Phone
- (714) 456-3526
Quick Facts
- NPI
- 1790579266
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile